Telmisartan Loaded Nanofibers Enhance Re-Endothelialization and Inhibit Neointimal Hyperplasia

Telmisartan Loaded Nanofibers Enhance Re-Endothelialization and Inhibit Neointimal Hyperplasia

Stent implantation impairs local endothelial function and may be associated with subsequent adverse cardiovascular events. Telmisartan, an angiotensin II receptor blocker that has unique peroxisome proliferator-activated-receptor-gamma-mediated effects on cardiovascular disease, has been shown to en...

Full description

Bibliographic Details
Main Authors:	Chen-Hung Lee, Kuo-Sheng Liu, Julien George Roth, Kuo-Chun Hung, Yen-Wei Liu, Shin-Huei Wang, Chi-Ching Kuo, Shih-Jung Liu
Format:	Article
Language:	English
Published:	MDPI AG 2021-10-01
Series:	Pharmaceutics
Subjects:	drug-loaded nanofibers telmisartan PLGA controlled release
Online Access:	https://www.mdpi.com/1999-4923/13/11/1756

Similar Items

Telmisartan and cardioprotection
by: McFarlane S
Published: (2011-11-01)

The potential anticancer activities of telmisartan – a literature review
by: Andriana Hadjiyianni, et al.
Published: (2023-09-01)

The Antihypertensive Efficacy of Chlorthalidone and Telmisartan in Indian Hypertensive Patients who were Uncontrolled with Hydrochlorothiazide and Telmisartan Combination-A Prospective and an Open Label Study
by: Suresh V Sagarad, et al.
Published: (2014-04-01)

Efecto de telmisartan sobre marcadores del remodelado óseo en pacientes hipertensos Telmisartan effect's on remodelling bone markers in hypertensive patients
by: J. L. Pérez-Castrillón, et al.
Published: (2012-02-01)

Comparative Study of High Dose Mono-Therapy of Amlodipine or Telmisartan, and Their Low Dose Combination in Mild to Moderate Hypertension
by: Jaswant Goyal, et al.
Published: (2014-06-01)

A multicenter, open-label study of the efficacy and safety of telmisartan in mild to moderate hypertensive patients
by: Plavnik Frida Liane, et al.
Published: (2002-01-01)

A TEMPOL and rapamycin loaded nanofiber-covered stent favors endothelialization and mitigates neointimal hyperplasia and local inflammation
by: Rui Wang, et al.
Published: (2023-01-01)

Immune pleiotropic effect of telmisartan in arterial hypertension
by: N. M. Agarkov, et al.
Published: (2022-07-01)

Telmisartan is effective to ameliorate metabolic syndrome in rat model – a preclinical report
by: Cheng KC, et al.
Published: (2018-12-01)

Understanding the pH Dependence of Supersaturation State—A Case Study of Telmisartan
by: Szabina Kádár, et al.
Published: (2022-08-01)

Efficient and improved synthesis of Telmisartan
by: A. Sanjeev Kumar, et al.
Published: (2010-03-01)

Effect of Telmisartan in amelioration inflammatory Responses Induced by Myocardial Ischemia/Reperfusion Injury IN male Mice
by: Najah Rayish Hadia, et al.
Published: (2017-12-01)

Features of change of intracardiac gemodynamics and functional state of myocardium under the impact of telmisartan in patients with hypertension
by: Koshlia V.I., et al.
Published: (2016-09-01)

Features of change of intracardiac gemodynamics and functional state of myocardium under the impact of telmisartan in patients with hypertension.
by: V. I. Koshlia, et al.
Published: (2015-09-01)

A Meta-analysis of antihypertensive effect of telmisartan versus candesartan in patients with essential hypertension
by: Di Zhao, et al.
Published: (2019-01-01)

A study of the effects Telmisartan on induced hyperlipidemia and atherosclerosis in male rabbits
by: Shatha M. Al-Safi, et al.
Published: (2010-06-01)

Effect of Telmisartan on the Regression of the Left Ventricular Hypertrophy in the Patients of Essential Hypertension
by: Kumar Haraprasad Misra, et al.
Published: (2013-07-01)

Antiproliferative and apoptotic effects of telmisartan in human glioma cells
by: Yung-Lung Chang, et al.
Published: (2023-06-01)

Sustained Release of Antifungal and Antibacterial Agents from Novel Hybrid Degradable Nanofibers for the Treatment of Polymicrobial Osteomyelitis
by: Yung-Heng Hsu, et al.
Published: (2023-02-01)

In Vitro Evaluation of Protective Effect of Telmisartan on Arsenic-Induced Genotoxicity
by: Neda Khorsandi, et al.
Published: (2019-01-01)

Simultaneous HPLC–UV analysis of telmisartan and hydrochlorothiazide in human plasma
by: Ismail Salama
Published: (2011-06-01)

TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY
by: V. I. Podzolkov, et al.
Published: (2015-12-01)

Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects
by: Kang WY, et al.
Published: (2018-03-01)

Detection, isolation and characterization of principle synthetic route indicative impurity in telmisartan
by: V. Srinivasan, et al.
Published: (2016-11-01)

Efficacy of Telmisartan in Pristane Induced Arthritis Rat Model
by: Quratulain Mehdi, et al.
Published: (2021-06-01)

Effects of telmisartan on metabolic syndrome components: a comprehensive review
by: Mohsen Imenshahidi, et al.
Published: (2024-02-01)

Influence of PRKCH gene polymorphism on antihypertensive response to amlodipine and telmisartan
by: Zan-Ling Zhang, et al.
Published: (2017-11-01)

Telmisartan Modulates the Oral Mucositis Induced by 5-Fluorouracil in Hamsters
by: Maisie M. Barbosa, et al.
Published: (2018-08-01)

Histopathological Evaluation of Protective Effect of Telmisartan against Radiation-Induced Bone Marrow Injury
by: Masoomeh Fooladi, et al.
Published: (2022-06-01)

Nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo
by: Lee CH, et al.
Published: (2019-09-01)

Thermal Analysis Study of Antihypertensive Drugs Telmisartan and Cilazapril
by: Refaat Ahmed Saber, et al.
Published: (2014-05-01)

Proniosomal Telmisartan Tablets: Formulation, in vitro Evaluation and in vivo Comparative Pharmacokinetic Study in Rabbits
by: Teaima MH, et al.
Published: (2020-03-01)

Telmisartan induces osteosarcoma cells growth inhibition and apoptosis via suppressing mTOR pathway
by: Wang Chao, et al.
Published: (2018-07-01)

Cardiometabolic properties of telmisartan: new perspectives for use
by: O. M. Drapkina, et al.
Published: (2015-12-01)

Directional Growth of cm-Long PLGA Nanofibers by a Simple and Fast Wet-Processing Method
by: Erik Betz-Güttner, et al.
Published: (2022-01-01)

Enhanced Diabetic Wound Healing Using Electrospun Biocompatible PLGA-Based Saxagliptin Fibrous Membranes
by: Chen-Hung Lee, et al.
Published: (2022-10-01)

Effect of Telmisartan Versus Captopril on Insulin Resistance in Hypertensive Type 2 Diabetic Patients
by: Adnan Ali Zainal, et al.
Published: (2014-12-01)

Effects of stress on behavior and resting-state fMRI in rats and evaluation of Telmisartan therapy in a stress-induced depression model
by: Junling Li, et al.
Published: (2018-10-01)

Biomedical applications of ferulic acid encapsulated electrospun nanofibers
by: Priya Vashisth, et al.
Published: (2015-12-01)

Effect of Telmisartan and Quercetin in 5 Fluorouracil-Induced Renal Toxicity in Rats
by: Ali HH, et al.
Published: (2022-11-01)